Clotrimazole
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00257 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 27 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acne (disease) | KG + DL |
| 2 | vulvovaginitis | KG + DL |
| 3 | postmenopausal atrophic vaginitis | KG + DL |
| 4 | trichomonal vulvovaginitis | KG + DL |
| 5 | tinea profunda | KG + DL |
| 6 | Majocchi granuloma | KG + DL |
| 7 | ectothrix infectious disease | KG + DL |
| 8 | endothrix infectious disease | KG + DL |
| 9 | superficial mycosis | KG + DL |
| 10 | dermatophytosis of scalp or beard | KG + DL |
| 11 | vulvitis | KG + DL |
| 12 | ulceration of vulva | KG + DL |
| 13 | vulvar neoplasm | KG + DL |
| 14 | vaginitis (disease) | KG + DL |
| 15 | herpetic vulvovaginitis | KG + DL |
| 16 | vaginal discharge | KG + DL |
| 17 | congenital candidiasis | KG + DL |
| 18 | neonatal candidiasis | KG + DL |
| 19 | candida glabrata | KG + DL |
| 20 | leukoplakia of vagina | KG + DL |
| 21 | bacterial vaginosis | KG + DL |
| 22 | candidiasis, invasive | KG + DL |
| 23 | papillary conjunctivitis | KG + DL |
| 24 | demodicidosis of sebaceous gland | KG + DL |
| 25 | punctate epithelial keratoconjunctivitis | KG + DL |
| 26 | zinc, elevated plasma | KG + DL |
| 27 | otomycosis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.